Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trialResearch in context

Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trialResearch in context

Summary: Background: Faecal microbiota transplantation (FMT) has demonstrated efficacy in treating gastrointestinal (GI) diseases, such as Clostridium difficile infection (CDI) and inflammatory bowel disease (IBD). GI dysfunction is a frequent and occasionally dominating symptom of progressive supr...

Full description

Bibliographic Details
Main Authors: Haiyan Tian, Jiuqi Wang, Renyi Feng, Rui Zhang, Han Liu, Chi Qin, Lin Meng, Yongkang Chen, Yu Fu, Dongxiao Liang, Xin Yuan, Yanping Zhai, Qingyong Zhu, Lingjing Jin, Junfang Teng, Xuebing Ding, Xuejing Wang
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:EClinicalMedicine
Subjects:
Progressive supranuclear palsy-Richardson's syndrome
Faecal microbiota transplantation
Intestinal microbiota
Gastrointestinal dysfunction
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023000652

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023000652

Similar Items